<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-22698" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Congenital and Infantile Hepatic Hemangioma</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Lewis</surname>
            <given-names>Deirdre</given-names>
          </name>
          <aff>UMMS-Baystate</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Vaidya</surname>
            <given-names>Ruben</given-names>
          </name>
          <aff>University of Massachusetts- Baystate</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Deirdre Lewis declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ruben Vaidya declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-22698.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Hemangiomas are benign vascular tumors that may involve either the skin or viscera. Infantile hemangioma (IH) grows rapidly after birth then involutes slowly whereas, congenital hemangioma (CH) is fully formed at birth and involutes in early infancy. Patients with hepatic hemangiomas may be clinically silent only detected on ultrasonography as an incidental finding. This activity describes the evaluation and management of hepatic hemangiomas and explains the role of the interprofessional team in improving care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the etiology of infantile hepatic hemangiomas.</p></list-item><list-item><p>Summarize the pathophysiology of infantile hepatic hemangioma.</p></list-item><list-item><p>Identify the use of corticosteroids in the management of infantile hepatic hemangiomas.</p></list-item><list-item><p>Review the importance of collaboration and communication among the interprofessional team to enhance the delivery of care for patients with hepatic hemangiomas.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22698&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22698">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-22698.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Hemangiomas are benign vascular tumors of infancy that may involve either the skin or viscera, including the liver. Understanding these lesions has advanced rapidly in the last several years, resolving previous wide variability in nomenclature and description. This article will focus on two distinct types of hemangioma: infantile hemangioma (IH) including infantile hepatic hemangioma (IHH) and congenital hemangioma (CH). They are notable for their varying clinical course. IH grows rapidly after birth then involutes slowly; whereas, CH is fully formed at birth and then involutes in early infancy.<xref ref-type="bibr" rid="article-22698.r1">[1]</xref> IHH may be further characterized by its pattern of involvement, whether focal, multifocal, or diffuse.<xref ref-type="bibr" rid="article-22698.r2">[2]</xref> CH may be further characterized by its pattern of involution, whether rapidly involuting (RICH), partially involuting (PICH), or non-involuting (NICH).<xref ref-type="bibr" rid="article-22698.r3">[3]</xref>&#x000a0;Awareness of these diagnoses is important as both IH and CH are expected to resolve on their own; however, serious complications may occur requiring further intervention.</p>
      </sec>
      <sec id="article-22698.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>IH and CH are both vascular tumors of infancy but differ in their underlying cause and clinical course. The underlying pathogenesis in both cases is only partially understood. In the case of IH, it is theorized lesions form as a product of dysregulation of vasculogenesis and angiogenesis. Hypoxic stress appears to be a triggering signal, prompting over-expression of VEG-F and other angiogenic factors, leading to an abnormal proliferation of fetal endothelial cells.<xref ref-type="bibr" rid="article-22698.r4">[4]</xref></p>
        <p>In the case of CH, somatic activating mutations are implicated in their pathogenesis. Recent studies have demonstrated mutations in the alleles GNAQ and GNA11 in CH. Interestingly, both RICH and NICH demonstrate similar mutations, suggesting their different clinical behavior may be the result of postnatal factors or epigenetics.<xref ref-type="bibr" rid="article-22698.r5">[5]</xref></p>
      </sec>
      <sec id="article-22698.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Infantile hemangiomas are the most common vascular tumor of infancy, affecting 4 to 5% of term infants with a female and white predominance.<xref ref-type="bibr" rid="article-22698.r4">[4]</xref> Similarly, IHH is the most common hepatic tumor of infancy. Risk factors include low birth weight, prematurity, and positive family history.&#x000a0; In contrast, CH is rare. The precise incidence is not known but likely occurs in less than 1% of all infants. In one case series CH represented only 14% of all vascular tumors of infancy.<xref ref-type="bibr" rid="article-22698.r6">[6]</xref> There are no reported risk factors for CH in the literature.</p>
      </sec>
      <sec id="article-22698.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Infantile hepatic hemangioma has been noted to have three distinct patterns of involvement: focal, multifocal, or diffuse.<xref ref-type="bibr" rid="article-22698.r2">[2]</xref></p>
        <p>Focal IHH is a single hepatic lesion that is typically asymptomatic and rarely associated with cutaneous IH. Of note, they also stain negative for GLUT-1, unlike other forms of IH, prompting some authors to pose that focal IH likely represents hepatic RICH.<xref ref-type="bibr" rid="article-22698.r1">[1]</xref><xref ref-type="bibr" rid="article-22698.r7">[7]</xref></p>
        <p>Multifocal IHH is comprised of several distinct lesions in the liver, variably defined in the literature as at least five lesions or up to ten lesions. They also are often asymptomatic, although they are more likely to cause high output heart failure due to arteriovenous or portovenous shunting.</p>
        <p>Diffuse IHH, also known as diffuse neonatal hemangiomatosis, is marked by significant liver involvement with near complete displacement of the liver parenchyma.<xref ref-type="bibr" rid="article-22698.r2">[2]</xref> These children are much more likely to come to medical attention for complications. First, the massive hepatomegaly can lead to compression of nearby local structures, including the thoracic cavity, inferior cava, and abdominal contents. This can lead to abdominal compartment syndrome, respiratory failure, and ultimately multisystem organ failure. Diffuse IHH may also overproduce type III iodothyronine deiodinase which deactivates thyroxine, leading to profound hypothyroidism. This can lead to significant developmental delay and cardiac failure due to poor contractility. High output cardiac failure due to the highly vascular nature of the lesion has been reported.</p>
        <p>CH may demonstrate three distinct patterns. Tumors may rapidly involute in infancy and are therefore known as rapidly involuting congenital hemangioma (RICH), do not involute and are therefore known as non-involuting congenital hemangioma (NICH), or partially involute and are known as partially involuting congenital hemangioma (PICH).<xref ref-type="bibr" rid="article-22698.r3">[3]</xref></p>
        <p>CH may be asymptomatic or identified on routine screening. When symptomatic, they may cause transient thrombocytopenia and coagulopathy, which is distinct from the Kasabach-Merritt phenomenon, an aggressive and life-threatening process exclusively associated with kaposiform hemangioendothelioma and tufted angioma<xref ref-type="bibr" rid="article-22698.r8">[8]</xref>. Other rare complications include disseminated intravascular coagulation, hepatic failure due to the displacement of liver parenchyma, and high output cardiac failure due to arteriovenous and portovenous shunting.</p>
      </sec>
      <sec id="article-22698.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>IH uniformly stains positive for the glucose transporter GLUT-1, which is considered pathognomonic for IH. In contrast, CH stains negative for GLUT-1.<xref ref-type="bibr" rid="article-22698.r1">[1]</xref><xref ref-type="bibr" rid="article-22698.r3">[3]</xref><xref ref-type="bibr" rid="article-22698.r4">[4]</xref></p>
      </sec>
      <sec id="article-22698.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Both IHH and hepatic CH may be clinically silent and may only be detected on ultrasonography performed for other indications, such as routine prenatal ultrasound. When of significant size, they may be detected as hepatomegaly on physical exam.</p>
        <p>Most lesions are asymptomatic at presentation. If symptomatic, presenting features may include high output heart failure, hypothyroidism, or compression of local structures, as discussed in the pathophysiology section. In the case of CH, a mild transient coagulopathy may produce a petechial rash.&#x000a0;</p>
        <p>In the case of multifocal and diffuse IHH, an association has been noted between cutaneous and hepatic IH. Multiple cutaneous IHs may indicate an underlying IHH. It is recommended if 5 or more cutaneous IH are noted the infant undergoes a liver ultrasound.<xref ref-type="bibr" rid="article-22698.r2">[2]</xref></p>
      </sec>
      <sec id="article-22698.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnosis of cutaneous IH and CH may be made on clinical grounds. However, hepatic lesions may not be fully assessed with physical exam alone. Definitive diagnosis of IH and CH may be made with biopsy and subsequent histopathological examination; however, this is often difficult as lesions are highly vascular and represent a bleeding risk. Therefore, clinical course, classic radiographic findings, and exclusion of malignant processes with laboratory studies can be used to make the diagnosis.&#x000a0;</p>
        <p>Diagnosis of IH and CH may be based on their clinical course. Both lesions should be monitored with serial ultrasounds. A lesion that grows rapidly from birth until about eight months of age then begins to regress is consistent with IH, whereas a lesion that is fully formed at birth and slowly regresses is consistent with CH.&#x000a0;</p>
        <p>Distinctive characteristics on imaging may be helpful in establishing the diagnosis of either CH or IH. In the case of CH, the lesion may appear strikingly heterogeneous on US, CT, or MRI, with a peripheral rim of contrast enhancement and minimal central enhancement.<xref ref-type="bibr" rid="article-22698.r9">[9]</xref><xref ref-type="bibr" rid="article-22698.r10">[10]</xref><xref ref-type="bibr" rid="article-22698.r11">[11]</xref><xref ref-type="bibr" rid="article-22698.r12">[12]</xref>&#x000a0;IH may have similar features. A possible distinguishing feature between the two may be calcifications, which are often present in CH but never present in IH.<xref ref-type="bibr" rid="article-22698.r13">[13]</xref></p>
        <p>In both cases, documentation of a falling serum AFP and negative urine catecholamines may be helpful in excluding hepatoblastoma or neuroblastoma.</p>
      </sec>
      <sec id="article-22698.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment of both IH and CH is supportive and aims to address potential complications, as both lesions generally resolve without intervention. Treatment is indicated in cases where complications are present.<xref ref-type="bibr" rid="article-22698.r4">[4]</xref></p>
        <p>Historically for IH, corticosteroids were the treatment of choice. In the case of cutaneous IH causing either disfigurement or interfering with vision, oral propranolol has become the treatment of choice. The exact mechanism is not understood but is theorized to regulate the VEGF pathway implicated in the lesion&#x02019;s development.<xref ref-type="bibr" rid="article-22698.r4">[4]</xref> Propranolol has also been shown to be effective for IHH.</p>
        <p>Surgical resection and embolization of IHH are reserved for cases of severe complications, including high output heart failure, abdominal compartment syndrome, and respiratory failure. Complications of surgical resection include bleeding, while embolization may lead to hepatic necrosis, cirrhosis, and sepsis. Infants with diffuse IHH with hypothyroidism will require thyroid replacement.&#x000a0;</p>
        <p>In congenital hemangioma, no medical therapy has been noted to induce regression of the lesion. Corticosteroids have been trialed in the past without success. Surgical resection or embolization may rarely be indicated in the setting of active bleeding or severe heart failure.</p>
        <p>In both cases, serial ultrasounds should be performed to document regression. IH grows rapidly in early infancy, typically reaches peak size by nine months, and is expected to regress by 80% by age 4, whereas RICH is expected to regress completely by 12 to 14 months.<xref ref-type="bibr" rid="article-22698.r14">[14]</xref><xref ref-type="bibr" rid="article-22698.r15">[15]</xref><xref ref-type="bibr" rid="article-22698.r16">[16]</xref>&#x000a0;Minimal regression or partial regression may be seen in NICH or PICH.</p>
      </sec>
      <sec id="article-22698.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Differential diagnosis of a hepatic hemangioma includes metastatic or atypical neuroblastoma, hepatoblastoma, mesenchymal hamartoma, kaposiform hemangioendothelioma, embryonal sarcoma, or angiosarcoma. Given the malignant potential of many of these lesions, careful evaluation and serial monitoring of the lesion is critical.<xref ref-type="bibr" rid="article-22698.r2">[2]</xref></p>
      </sec>
      <sec id="article-22698.s11" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Considerable confusion exists in the literature regarding the nomenclature of these lesions, which has been clarified in recent years. Infantile hemangioma historically may be referred to as &#x0201c;infantile hemangioendothelioma,&#x0201d; a term which is not preferred due to its implication for malignant potential and the potential confusion with &#x0201c;kaposiform hemangioendothelioma&#x0201d; or &#x0201c;epithelioid hemangioendothelioma&#x0201d; a malignant vascular tumor of infancy. Both IH and CH should be distinguished from the hepatic hemangiomas of adulthood which is a separate disease process.</p>
      </sec>
      <sec id="article-22698.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Hepatic hemangiomas are benign vascular tumors of infancy involving the liver, with two distinct types, including infantile hepatic hemangioma (IHH) and congenital hemangioma (CH). Diagnosis of types is generally based on their clinical course, but it is important to note that both the lesions are expected to resolve over time.&#x000a0;Both lesions&#x000a0;require close monitoring with serial ultrasounds and generally do not require specific intervention, and&#x000a0;only needing supportive treatment focussing on&#x000a0;the complications. These lesions should be closely followed by an interprofessional team consisting of a pediatrician or nurse practitioner, with a pediatric hematologist/oncologist, with serial imaging and close monitoring for complications. [Level 5]</p>
      </sec>
      <sec id="article-22698.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22698&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22698">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/gut-health/congenital-and-infantile-hepatic-hemangioma/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=22698">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/22698/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=22698">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-22698.s14">
        <title>References</title>
        <ref id="article-22698.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roebuck</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sebire</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lehmann</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Barnacle</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Rapidly involuting congenital haemangioma (RICH) of the liver.</article-title>
            <source>Pediatr Radiol</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>42</volume>
            <issue>3</issue>
            <fpage>308</fpage>
            <page-range>308-14</page-range>
            <pub-id pub-id-type="pmid">22302317</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22698.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gnarra</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Behr</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kitajewski</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Anupindi</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Shawber</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Zavras</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Schizas</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Salakos</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Economopoulos</surname>
                <given-names>KP</given-names>
              </name>
            </person-group>
            <article-title>History of the infantile hepatic hemangioma: From imaging to generating a differential diagnosis.</article-title>
            <source>World J Clin Pediatr</source>
            <year>2016</year>
            <month>Aug</month>
            <day>08</day>
            <volume>5</volume>
            <issue>3</issue>
            <fpage>273</fpage>
            <page-range>273-80</page-range>
            <pub-id pub-id-type="pmid">27610342</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22698.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berenguer</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mulliken</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Enjolras</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Boon</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Wassef</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Josset</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Burrows</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Perez-Atayde</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Kozakewich</surname>
                <given-names>HP</given-names>
              </name>
            </person-group>
            <article-title>Rapidly involuting congenital hemangioma: clinical and histopathologic features.</article-title>
            <source>Pediatr Dev Pathol</source>
            <year>2003</year>
            <season>Nov-Dec</season>
            <volume>6</volume>
            <issue>6</issue>
            <fpage>495</fpage>
            <page-range>495-510</page-range>
            <pub-id pub-id-type="pmid">15018449</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22698.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>L&#x000e9;aut&#x000e9;-Labr&#x000e8;ze</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Harper</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Hoeger</surname>
                <given-names>PH</given-names>
              </name>
            </person-group>
            <article-title>Infantile haemangioma.</article-title>
            <source>Lancet</source>
            <year>2017</year>
            <month>Jul</month>
            <day>01</day>
            <volume>390</volume>
            <issue>10089</issue>
            <fpage>85</fpage>
            <page-range>85-94</page-range>
            <pub-id pub-id-type="pmid">28089471</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22698.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ayturk</surname>
                <given-names>UM</given-names>
              </name>
              <name>
                <surname>Couto</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Hann</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mulliken</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Fishman</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Boyd</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Kozakewich</surname>
                <given-names>HPW</given-names>
              </name>
              <name>
                <surname>Bischoff</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Greene</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Warman</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Somatic Activating Mutations in GNAQ and GNA11 Are Associated with Congenital Hemangioma.</article-title>
            <source>Am J Hum Genet</source>
            <year>2016</year>
            <month>Jun</month>
            <day>02</day>
            <volume>98</volume>
            <issue>6</issue>
            <fpage>1271</fpage>
            <pub-id pub-id-type="pmid">27259057</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22698.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>LX</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Clinical Characteristics and Treatment Options of Infantile Vascular Anomalies.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>94</volume>
            <issue>40</issue>
            <fpage>e1717</fpage>
            <pub-id pub-id-type="pmid">26448027</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22698.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Christison-Lagay</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Burrows</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Alomari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dubois</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kozakewich</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>Lane</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Paltiel</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Klement</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mulliken</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Fishman</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry.</article-title>
            <source>J Pediatr Surg</source>
            <year>2007</year>
            <month>Jan</month>
            <volume>42</volume>
            <issue>1</issue>
            <fpage>62</fpage>
            <page-range>62-7; discussion 67-8</page-range>
            <pub-id pub-id-type="pmid">17208542</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22698.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lewis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hachey</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Fitzgerald</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vaidya</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Rapidly involuting congenital haemangioma of the liver.</article-title>
            <source>BMJ Case Rep</source>
            <year>2018</year>
            <month>Jun</month>
            <day>05</day>
            <volume>2018</volume>
            <pub-id pub-id-type="pmid">29871961</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22698.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mortel&#x000e9;</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Vanzieleghem</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mortel&#x000e9;</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Benoit</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ros</surname>
                <given-names>PR</given-names>
              </name>
            </person-group>
            <article-title>Solitary hepatic infantile hemangioendothelioma: dynamic gadolinium-enhanced MR imaging findings.</article-title>
            <source>Eur Radiol</source>
            <year>2002</year>
            <month>Apr</month>
            <volume>12</volume>
            <issue>4</issue>
            <fpage>862</fpage>
            <page-range>862-5</page-range>
            <pub-id pub-id-type="pmid">11960239</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22698.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zenge</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Fenton</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lovell</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Grover</surname>
                <given-names>TR</given-names>
              </name>
            </person-group>
            <article-title>Case report: infantile hemangioendothelioma.</article-title>
            <source>Curr Opin Pediatr</source>
            <year>2002</year>
            <month>Feb</month>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>99</fpage>
            <page-range>99-102</page-range>
            <pub-id pub-id-type="pmid">11880743</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22698.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Keslar</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Buck</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Selby</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>From the archives of the AFIP. Infantile hemangioendothelioma of the liver revisited.</article-title>
            <source>Radiographics</source>
            <year>1993</year>
            <month>May</month>
            <volume>13</volume>
            <issue>3</issue>
            <fpage>657</fpage>
            <page-range>657-70</page-range>
            <pub-id pub-id-type="pmid">8316672</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22698.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peddu</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kane</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Karani</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Knisely</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>Vanishing liver tumours.</article-title>
            <source>Clin Radiol</source>
            <year>2008</year>
            <month>Mar</month>
            <volume>63</volume>
            <issue>3</issue>
            <fpage>329</fpage>
            <page-range>329-39</page-range>
            <pub-id pub-id-type="pmid">18275874</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22698.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gorincour</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kokta</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Rypens</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Garel</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Powell</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dubois</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Imaging characteristics of two subtypes of congenital hemangiomas: rapidly involuting congenital hemangiomas and non-involuting congenital hemangiomas.</article-title>
            <source>Pediatr Radiol</source>
            <year>2005</year>
            <month>Dec</month>
            <volume>35</volume>
            <issue>12</issue>
            <fpage>1178</fpage>
            <page-range>1178-85</page-range>
            <pub-id pub-id-type="pmid">16078073</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22698.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boon</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Enjolras</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Mulliken</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>Congenital hemangioma: evidence of accelerated involution.</article-title>
            <source>J Pediatr</source>
            <year>1996</year>
            <month>Mar</month>
            <volume>128</volume>
            <issue>3</issue>
            <fpage>329</fpage>
            <page-range>329-35</page-range>
            <pub-id pub-id-type="pmid">8774499</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22698.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krol</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>MacArthur</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Congenital hemangiomas: rapidly involuting and noninvoluting congenital hemangiomas.</article-title>
            <source>Arch Facial Plast Surg</source>
            <year>2005</year>
            <season>Sep-Oct</season>
            <volume>7</volume>
            <issue>5</issue>
            <fpage>307</fpage>
            <page-range>307-11</page-range>
            <pub-id pub-id-type="pmid">16172338</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22698.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Browning</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Metry</surname>
                <given-names>DW</given-names>
              </name>
            </person-group>
            <article-title>Rapidly involuting congenital hemangioma: case report and review of the literature.</article-title>
            <source>Dermatol Online J</source>
            <year>2008</year>
            <month>Apr</month>
            <day>15</day>
            <volume>14</volume>
            <issue>4</issue>
            <fpage>11</fpage>
            <pub-id pub-id-type="pmid">18627733</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
